PMDA Eyes More Japan-First Approvals In Access Push

Highlighting progress it has made over the past few years, Japan’s regulatory agency says it wants to raise even further the number of “Japan-first” approvals, as part of its stated mission to get safe and effective new drugs to patients more quickly.

pill with Japanese flag
Japan's Regulator Aims For More Global-First Approvals • Source: Shutterstock

Despite what it sees as improvements across multiple regulatory fronts over the past few years, Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) says “there still exists room for improvement” to increase the number of new drug approvals it issues ahead of any other country.

In a new activity update, chief executive Yasuhiro Fujiwara points out that the number of such clearances has already been...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Japan

More from Asia